about
Clinical spectrum of cryoglobulinaemic neuropathyInfection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general populationRelative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon SystemGeographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data.A Hospital-based Retrospective Study on Frequency and Distribution of Viral HepatitisA pharmacoeconomic appraisal of therapies for hepatitis B and C.Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1).Detecting viruses by using salivary diagnostics.Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.Hepatitis C in alcohol dependence:drinking versus disulfiram.Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findingsMedical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment.Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine CandidateNew therapeutic opportunities for hepatitis C based on small RNA.A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and productionProspects of RNAi and microRNA-based therapies for hepatitis C.In vivo modeling of human liver for pharmacological study using humanized mouse.A human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humansAAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?"Three in the Room": Embodiment, Disclosure, and Vulnerability in Qualitative Research.Adenovirus vector-mediated assay system for hepatitis C virus replication.Determination of hepatitis C genotypes and the viral titer distribution in children and adolescents with major thalassemia.Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase.Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase.Effect of metal ion binding on the structural stability of the hepatitis C virus RNA polymerase.The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.In search of the correct strategy for preventing the spread of HCV infection.Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein.Characterization of the metal ion binding properties of the hepatitis C virus RNA polymerase.Of mice and men, calcineurin inhibitors and hepatitis C.Modulation of hepatitis C virus RNA-dependent RNA polymerase activity by structure-based site-directed mutagenesis.Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C.Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population.The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost Analysis
P2860
Q27477873-EA997B38-7066-44B1-BC3F-33209B20C427Q27477954-3C1332AD-ECD6-495D-8D6A-F0AF68F3BA4EQ27485441-FDB52605-43F5-40EA-A910-B4B9F2E76F0CQ31155390-E58B69EC-4931-4B7E-B2C7-EAF93DC2DFF4Q34101454-7D8C5909-C286-493C-B584-313A58A0AC7AQ34240802-8561BC0C-452E-4D93-9245-00BBB086D4B8Q34308953-01C20560-2168-4621-B5DD-60156BC5342AQ34605831-150740D9-7FC0-4FDF-8241-3A0642342407Q34675315-A89F41DF-C216-47A9-9DCB-63C3AC98269DQ35738851-F1574226-43A7-4BD6-AA80-DF5303D92E68Q36077526-987006B0-32C7-4202-937D-D86C6441801AQ36263653-2B6C8862-FE48-4519-86F6-ADF20F97E4C6Q36311018-C177B92C-2E01-413C-BF99-68DEEF3DEC4AQ36573679-5E40DC1F-A1C4-422B-AE25-E079C473682EQ36921336-2E1F3C91-7CCB-4931-A4D4-D10B8E26C2E7Q37153341-ABC2B2AB-1989-4848-A3EF-5E31084CF7BEQ37489877-D935BCEA-FD79-459E-9F09-D83A4363BBE6Q37588714-4CABAB93-C3F2-46F6-AA73-E0876137DB88Q37626434-756A99F9-2B57-42B5-9A35-649DF5F3D516Q37825907-D9B89FC9-A79D-4EE9-B34B-D5CA898E6F48Q39050406-5E0A0348-B4B0-4867-A17A-7F7E0A9CD1D6Q39595299-8B25FD6E-C410-4715-923A-AA38403331ABQ41835172-6DC0C34A-25BC-482B-906D-B5CAFD8DF21CQ42267147-5C12A5AE-3067-410E-9364-5247FB9B97CAQ42980718-A9BC7370-8782-46D6-8567-213562772790Q42987667-F5DF7CCA-7005-4A95-AC13-8F1F0DA47DC4Q42989340-D32617A3-B895-4BAF-9695-F9BDF6371CB2Q42997993-7FBE4AA5-E38C-4F85-AB16-C81DBA9D6702Q43005087-3384A936-A68B-4695-8637-E3D7EBEF625BQ43040060-E664A85A-B552-4C04-BCF3-B67543DF7B29Q43041233-88BF89D4-2D7B-42CF-BD81-594E903F18B9Q43041850-D62C1962-208B-41CF-BD0A-A4C5F695CE51Q44081160-98D28533-9CCA-49DE-BD82-76FC075AA722Q44183496-6163EFD4-A890-451D-B1D1-531AEF50D54CQ44924772-E210180A-1C06-4B5F-8274-B0171911FA99Q45421753-B5A72F26-CEEC-4086-B2D6-41E3A3C5FA88Q56654940-663B8078-6B43-470A-A930-797E23A689A2
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hepatitis C: an update on the silent epidemic.
@ast
Hepatitis C: an update on the silent epidemic.
@en
type
label
Hepatitis C: an update on the silent epidemic.
@ast
Hepatitis C: an update on the silent epidemic.
@en
prefLabel
Hepatitis C: an update on the silent epidemic.
@ast
Hepatitis C: an update on the silent epidemic.
@en
P1476
Hepatitis C: an update on the silent epidemic.
@en
P2093
Younossi ZM
P304
P356
10.1097/00004836-200003000-00005
P577
2000-03-01T00:00:00Z